NLRP3 and cardiovascular disorder: However, while evidence supports the role of DL-all-rac-α-tocopherol in inhibiting Lamtor1-HDAC6 interactions and reducing NLRP3 activation under inflammatory conditions, its effects on cardiovascular disease remain inconclusive.